Discuss the ways in which the natural monopoly model is a good fit for describing the pharmaceutical industry. What are the regulatory remedies to the problems that arise from an unregulated natural monopoly? What are the relatives strengths and weaknesses of the regulatory options? If you were setting policy, which one would you choose and why?